The Functional Role of the Renin-Angiotensin System in Pregnancy and Preeclampsia

Placenta

Volumn 29, Issue 9, 2008, Pages 763-771

  Irani, R A ^a   Xia, Y ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ANG II; angiotensin II; angiotensin II type I receptor agonistic autoantibody; AT1 AA; placenta; preeclampsia; RAS; renin angiotensin system; sFlt 1; soluble fms like tyrosine kinase 1

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II ANTIBODY; AUTOANTIBODY; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; RENIN; THROMBOPLASTIN; VASCULOTROPIN;

CLINICAL FEATURE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MATERNAL MORBIDITY; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; AUTOANTIBODIES; CALCIUM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; PEPTIDYL-DIPEPTIDASE A; PLACENTA; PLACENTA DISEASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 50049128841     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.06.011     Document Type: Review

References (105)

1. Jensen B.L., Schmid C., and Kurtz A. Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol 271 3 Pt 2 (1996) F659-F669
2. Chung O., Kuhl H., Stoll M., and Unger T. Physiological and pharmacological implications of AT1 versus AT2 receptors. Kidney Int 54 S67 (1998) S95-S99
3. Ozono R., Wang Z.Q., Moore A.F., Inagami T., Siragy H.M., and Carey R.M. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30 5 (1997) 1238-1246
4. Grishko V., Pastukh V., Solodushko V., Gillespie M., Azuma J., and Schaffer S. Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol 285 6 (2003) H2364-H2372
5. Wang Y., Gu Y., Zhang Y., Lewis D.F., Alexander J.S., and Granger D.N. Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia. Placenta 28 4 (2007) 263-269
6. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., and Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265 36 (1990) 22348-22357
7. Caughey G.H., Schaumberg T.H., Zerweck E.H., Butterfield J.H., Hanson R.D., Silverman G.A., et al. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 15 3 (1993) 614-620
8. Hagemann A., Nielsen A.H., and Poulsen K. The uteroplacental renin-angiotensin system: a review. Exp Clin Endocrinol 102 3 (1994) 252-261
9. Poisner A.M. The human placental renin-angiotensin system. Front Neuroendocrinol 19 3 (1998) 232-252
10. Hodari A.A., Smeby R., and Bumpus F.M. A renin-like substance in the human placenta. Obstet Gynecol 29 3 (1967) 313-317
11. Symonds E.M., Stanley M.A., and Skinner S.L. Production of renin by in vitro cultures of human chorion and uterine muscle. Nature 217 5134 (1968) 1152-1153
12. Li X., Shams M., Zhu J., Khalig A., Wilkes M., Whittle M., et al. Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest 101 2 (1998) 442-454
13. Shaw K.J., Do Y.S., Kjos S., Anderson P.W., Shinagawa T., Dubeau L., et al. Human decidua is a major source of renin. J Clin Invest 83 6 (1989) 2085-2092
14. Li C., Ansari R., Yu Z., and Shah D. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 36 2 (2000) 159-164
15. Morgan T., Craven C., and Ward K. Human spiral artery renin-angiotensin system. Hypertension 32 4 (1998) 683-687
16. Hsueh W.A., Luetscher J.A., Carlson E.J., Grislis G., Fraze E., and McHargue A. Changes in active and inactive renin throughout pregnancy. J Clin Endocrinol Metab 54 5 (1982) 1010-1016
17. Brown M.A., Gallery E.D., Ross M.R., and Esber R.P. Sodium excretion in normal and hypertensive pregnancy: a prospective study. Am J Obstet Gynecol 159 2 (1988) 297-307
18. Merrill D.C., Karoly M., Chen K., Ferrario C.M., and Brosnihan K.B. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 18 3 (2002) 239-245
19. Assali N.S., and Westersten A. Regional flow-pressure relationship in response to angiotensin in the intact dog and sheep. Circ Res 9 (1961) 189-193
20. Gant N.F., Worley R.J., Everett R.B., and MacDonald P.C. Control of vascular responsiveness during human pregnancy. Kidney Int 18 2 (1980) 253-258
21. AbdAlla S., Lother H., el Massiery A., and Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7 9 (2001) 1003-1009
22. Dechend R., Viedt C., Muller D.N., Ugele B., Brandes R.P., Wallukat G., et al. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107 12 (2003) 1632-1639
23. Shibata E., Powers R.W., Rajakumar A., von Versen-Hoynck F., Gallaher M.J., Lykins D.L., et al. Angiotensin II decreases system A amino acid transporter activity in human placental villous fragments through AT1 receptor activation. Am J Physiol Endocrinol Metab 291 5 (2006) E1009-E1016
24. Takimoto E., Ishida J., Sugiyama F., Horiguchi H., Murakami K., and Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274 5289 (1996) 995-998
25. Xia Y., Wen H., Prashner H.R., Chen R., Inagami T., Catanzaro D.F., et al. Pregnancy-induced changes in renin gene expression in mice. Biol Reprod 66 1 (2002) 135-143
26. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
27. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 5728 (2005) 1592-1594
28. Santos R.A., Haibara A.S., Campagnole-Santos M.J., Simoes e Silva A.C., Paula R.D., Pinheiro S.V., et al. Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). Hypertension 41 3 Pt 2 (2003) 737-743
29. Handa R.K. Angiotensin-(1-7) can interact with the rat proximal tubule AT(4) receptor system. Am J Physiol 277 1 Pt 2 (1999) F75-F83
30. Handa R.K. Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J Am Soc Nephrol 11 8 (2000) 1377-1386
31. Gant N.F., Daley G.L., Chand S., Whalley P.J., and MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52 11 (1973) 2682-2689
32. Quitterer U., Lother H., and Abdalla S. AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin Nephrol 24 2 (2004) 115-119
33. AbdAlla S., Abdel-Baset A., Lother H., el Massiery A., and Quitterer U. Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J Mol Neurosci 26 2-3 (2005) 185-192
34. Ariza A.C., Bobadilla N.A., and Halhali A. [Endothelin 1 and angiotensin II in preeeclampsia]. Rev Invest Clin 59 1 (2007) 48-56
35. Herse F., Dechend R., Harsem N.K., Wallukat G., Janke J., Qadri F., et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49 3 (2007) 604-611
36. Shah D.M., Banu J.M., Chirgwin J.M., and Tekmal R.R. Reproductive tissue renin gene expression in preeclampsia. Hypertens Pregnancy 19 3 (2000) 341-351
37. Anton L., Merrill D.C., Neves L.A., Stovall K., Gallagher P.E., Diz D.I., et al. Activation of Local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 51 4 (2008) 1066-1072
38. Schechter N.M., Wang Z.M., Blacher R.W., Lessin S.R., Lazarus G.S., and Rubin H. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. J Immunol 152 8 (1994) 4062-4069
39. Muto T., and Fukami H. Recent chymase inhibitors and their effects in in vivo models. IDrugs 5 12 (2002) 1141-1150
40. Ju H., Gros R., You X., Tsang S., Husain M., and Rabinovitch M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A 98 13 (2001) 7469-7474
41. Nakano A., Kishi F., Minami K., Wakabayashi H., Nakaya Y., and Kido H. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J Immunol 159 4 (1997) 1987-1992
42. Mitani R., Maeda K., Fukui R., Endo S., Saijo Y., Shinohara K., et al. Production of human mast cell chymase in human myometrium and placenta in cases of normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 101 2 (2002) 155-160
43. Takeji T., Nakaya Y., Kamada M., Maeda K., Saijo Y., Mitani R., et al. Effect of a novel vasoconstrictor endothelin-1 (1-31) on human umbilical artery. Biochem Biophys Res Commun 270 2 (2000) 622-624
44. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jupner A., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103 (1999) 945-952
45. Karumanchi S.A., and Epstein F.H. Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?. Kidney Int 71 10 (2007) 959-961
46. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
47. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 90 (1993) 10705-10709
48. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226 2 (1996) 324-328
49. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26 1 (2001) 25-35
50. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
51. Tsatsaris V., Goffin F., Munaut C., Brichant J.-F., Pignon M.-R., Noel A., et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88 (2003) 5555-5563
52. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 5 (2003) 649-658
53. Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145 (2004) 4838-4845
54. Khaliq A., Dunk C., Jiang J., Shams M., Li X.F., Acevedo C., et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 79 2 (1999) 151-170
55. Ahmed A., Dunk C., Ahmad S., and Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. Placenta 21 Suppl. A (2000) S16-S24
56. Lash G.E., Taylor C.M., Trew A.J., Cooper S., Anthony F.W., Wheeler T., et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 20 4 (2002) 189-196
57. Karumanchi S.A., and Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 145 (2004) 4835-4837
58. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103 12 (1999) 1641-1650
59. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest 105 5 (2000) 577-587
60. Soleymanlou N., Jurisica I., Nevo O., Ietta F., Zhang X., Zamudio S., et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90 7 (2005) 4299-4308
61. Zhou C.C., Ahmad S., Mi T., Abbasi S., Xia L., Day M.C., et al. Autoantibody from women with preeclampsia induces soluble fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51 4 (2008) 1010-1019
62. Zhou C.C., Ahmad S., Mi T., Xia L., Abbasi S., Hewett P.W., et al. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 100 1 (2007) 88-95
63. Bobst S.M., Day M.C., Gilstrap III L.C., Xia Y., and Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 18 3 (2005) 330-336
64. Xia Y., Wen H., Bobst S., Day M.C., and Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Invest 10 2 (2003) 82-93
65. Xia Y., Wen H.Y., and Kellems R.E. Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation. J Biol Chem 277 27 (2002) 24601-24608
66. Gutteridge J.M., and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899 (2000) 136-147
67. Burton G.J., Hempstock J., and Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 6 1 (2003) 84-96
68. van Tuyl M., Liu J., Wang J., Kuliszewski M., Tibboel D., and Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 288 1 (2005) L167-L178
69. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 3 (1999) 222-235
70. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 5 (1989) 1200-1204
71. Fay W.P. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends Cardiovasc Med 14 5 (2004) 196-202
72. Nakamura S., Nakamura I., Ma L., Vaughan D.E., and Fogo A.B. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int 58 1 (2000) 251-259
73. Fogo A.B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 35 2 (2000) 179-188
74. Petrucco O.M., Thomson N.M., Lawrence J.R., and Weldon M.W. Immunofluorescent studies in renal biopsies in pre-eclampsia. BMJ 1 5906 (1974) 473-476
75. Packham D.K., Mathews D.C., Fairley K.F., Whitworth J.A., and Kincaid-Smith P.S. Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum. Kidney Int 34 5 (1988) 704-711
76. Erlich J.H., Holdsworth S.R., and Tipping P.G. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol 150 3 (1997) 873-880
77. Xu Y., Berrou J., Chen X., Fouqueray B., Callard P., Sraer J.D., et al. Induction of urokinase receptor expression in nephrotoxic nephritis. Exp Nephrol 9 6 (2001) 397-404
78. Haller H O.T., Hauck U., Distler A., and Philipp T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens 2 4 (1989) 238-243
79. Hojo M., Suthanthiran M., Helseth G., and August P. Lymphocyte intracellular free calcium concentration is increased in preeclampsia. Am J Obstet Gynecol 180 5 (1999) 1209-1214
80. Ray J., Vasishta K., Kaur S., Majumdar S., and Sawhney H. Calcium metabolism in pre-eclampsia. Int J Gynaecol Obstet 66 3 (1999) 245-250
81. Sowers J.R., Zemel M.B., Bronsteen R.A., Zemel P.C., Walsh M.F., Standley P.R., et al. Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol 161 2 (1989) 441-445
82. 2+ mobilization through angiotensin receptor activation. Circulation 110 12 (2004) 1612-1619
83. Dechend R., Homuth V., Wallukat G., Kreuzer J., Park J.K., Theuer J., et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101 20 (2000) 2382-2387
84. Dorffel Y., Wallukat G., Bochnig N., Homuth V., Herberg M., Dorffel W., et al. Agonistic AT(1) receptor autoantibodies and monocyte stimulation in hypertensive patients. Am J Hypertens 16 10 (2003) 827-833
85. Bellamy L., Casas J.P., Hingorani A.D., and Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335 7627 (2007) 974
86. Fu M.L., Herlitz H., Schulze W., Wallukat G., Micke P., Eftekhari P., et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 18 7 (2000) 945-953
87. Georgiades P., Ferguson-Smith A.C., and Burton G.J. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23 1 (2002) 3-19
88. Saito T., Ishida J., Takimoto-Ohnishi E., Takamine S., Shimizu T., Sugaya T., et al. An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J 18 2 (2004) 388-390
89. Dechend R., Gratze P., Wallukat G., Shagdarsuren E., Plehm R., Brasen J.H., et al. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45 4 (2005) 742-746
90. Granger J.P., LaMarca B.B., Cockrell K., Sedeek M., Balzi C., Chandler D., et al. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122 (2006) 383-392
91. Dechend R., Llinas M., Caluwaerts S., Herse F., Lamarca B., Mueller D.N., et al. Agonistic autoantibodies to the AT1 receptor in rat models of preeclampsia: induced by chronic reduction in uterine perfusion pressure (RUPP) and low dose TNF-a infusion. Hypertens Pregnancy 25 (2006) 70 [abstract]
92. Pearce S.H., and Merriman T.R. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 12 (2006) 90-98
93. Fujinami R.S., von Herrath M.G., Christen U., and Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19 (2006) 80-94
94. Barak Y. The immune system and happiness. Autoimmun Rev 5 (2006) 523-527
95. Redman C.W., and Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta 21 (2000) 597-602
96. Benyo D.F., Smarason A., Redman C.W., Sims C., and Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86 6 (2001) 2505-2512
97. Borzychowski A.M., Sargent I.L., and Redman C.W. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 11 (2006) 309-316
98. Schiessl B. Inflammatory response in preeclampsia. Mol Aspects Med 28 2 (2007) 210-219
99. Alexander B.T., Cockrell K., Cline F.D., Llinas M.T., Sedeek M., and Granger J.P. Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats. Hypertension 38 3 Pt 2 (2001) 742-745
100. Roberts L., LaMarca B.B., Fournier L., Bain J., Cockrell K., and Granger J.P. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 47 3 (2006) 615-618
101. Langer B., Grima M., Coquard C., Bader A.M., Schlaeder G., and Imbs J.L. Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet Gynecol 91 2 (1998) 196-202
102. Brown M.A., Zammit V.C., Mitar D.A., and Whitworth J.A. Renin-aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens 5 6 Pt 1 (1992) 366-371
103. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., and McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161 5 (1989) 1200-1204
104. Roberts J.M., Edep M.E., Goldfien A., and Taylor R.N. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 27 3-4 (1992) 101-108
105. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med, in press.